Ceralasertib
D5330C00014
Phase 1 small_molecule completed
Quick answer
Ceralasertib for Advanced Solid Malignancies is a Phase 1 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Advanced Solid Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed